0001062993-24-006510.txt : 20240315
0001062993-24-006510.hdr.sgml : 20240315
20240315160217
ACCESSION NUMBER: 0001062993-24-006510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quinlan Paul T
CENTRAL INDEX KEY: 0001333277
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 24754619
BUSINESS ADDRESS:
BUSINESS PHONE: 510-293-8123
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7575 GATEWAY BLVD., SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-03-13
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001333277
Quinlan Paul T
C/O CYMABAY THERAPEUTICS, INC.
7601 DUMBARTON CIRCLE
FREMONT
CA
94555
0
1
0
0
General Counsel
0
Common Stock
2024-03-13
4
M
0
41824
7.89
A
70262
D
Employee Stock Option (right to buy)
7.89
2024-03-13
4
M
0
41824
0
D
2030-10-11
Common Stock
41824
8872
D
The option grant vests as to 1/4 of the underlying shares on October 12, 2021 and as to 1/48 of the underlying shares monthly thereafter.
/s/ Paul Quinlan
2024-03-15